Title Association between angiotensin-converting enzyme inhibitors and the risk of lung cancer: a systematic review and meta-analysis
Authors Wu, Zhenchao
Yao, Taikang
Wang, Zilu
Liu, Beibei
Wu, Nan
Lu, Ming
Shen, Ning
Affiliation Peking Univ Third Hosp, Dept Pulm & Crit Care Med, Beijing 100191, Peoples R China
Peking Univ, Hlth Sci Ctr, Beijing 100191, Peoples R China
Keywords ADVERSE DRUG-REACTIONS
RECEPTOR BLOCKERS
BLOOD-PRESSURE
SUBSTANCE-P
CAPTOPRIL
GROWTH
STATINS
TRIALS
Issue Date Nov-2022
Publisher BRITISH JOURNAL OF CANCER
Abstract Background The association between the use of angiotensin-converting enzyme inhibitors (ACEIs) and lung cancer risk remains controversial. This study evaluated the association between the use of ACEIs and lung cancer risk. Methods Records from five databases were searched from inception to 26 January 2022. Clinical studies involving persons aged >= 18 years with at least one year of follow-up and reporting adverse events, including lung cancer, were recorded with separate outcome reports supplied for the ACEIs and control groups. Data were extracted independently by three authors and pooled using a random-effects model. The primary outcome was lung cancer development. Odds ratios (ORs) with 95% confidence intervals (CIs) and lung cancer-related morbidity were calculated. Results Of 2400 records screened, 13,061,226 patients were included from seven cohort studies and four case-control studies. Pooled results showed that ACEIs use was linked to increased lung cancer risk (OR 1.19, 95% CI 1.05-1.36; P = 0.008), with high heterogeneity (I-2 = 98%). Conclusions ACEI usage is a greater risk factor for lung carcinogenesis than angiotensin receptor blocker use, especially in Asian patients. Further randomised controlled trials are needed to confirm the causal association between the use of ACEIs and lung cancer risk.
URI http://hdl.handle.net/20.500.11897/659193
ISSN 0007-0920
DOI 10.1038/s41416-022-02029-5
Indexed SCI(E)
Appears in Collections: 第三医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.